Abstract:The complexity of the heart makes an intuitive understanding of the relative contribution of ion channels, transporters and signalling pathways to cardiac electrophysiology challenging. Computational modelling of cardiac cellular electrophysiology has proven useful to integrate experimental findings, extrapolate results obtained in expression systems or animal models to other systems, test quantitatively ideas based on experimental data and provide novel hypotheses that are experimentally testable. While the bulk of computational modelling has traditionally been directed towards ventricular bioelectricity, increasing recognition of the clinical importance of atrial arrhythmias, particularly atrial fibrillation, has led to widespread efforts to apply computational approaches to understanding atrial electrical function. The increasing availability of detailed, atrial-specific experimental data has stimulated the development of novel computational models of atrial-cellular electrophysiology and Ca(2+) handling. To date, more than 300 studies have employed mathematical simulations to enhance our understanding of atrial electrophysiology, arrhythmogenesis and therapeutic responses. Future modelling studies are likely to move beyond current whole-cell models by incorporating new data on subcellular architecture, macromolecular protein complexes, and localized ion-channel regulation by signalling pathways. At the same time, more integrative multicellular models that take into account regional electrophysiological and Ca(2+) handling properties, mechano-electrical feedback and/or autonomic regulation will be needed to investigate the mechanisms governing atrial arrhythmias. A combined experimental and computational approach is expected to provide the more comprehensive understanding of atrial arrhythmogenesis that is required to develop improved diagnostic and therapeutic options. Here, we review this rapidly expanding area, with a particular focus on Ca(2+) handling, and provide ideas about potential future directions.

Theoretical Models and Computational Analysis of Action Potential Dispersion for Cardiac Arrhythmia Risk Stratification

Current Progress of Computational Modeling for Guiding Clinical Atrial Fibrillation Ablation.

Study the Effect of Tissue Heterogeneity and Anisotropy in Atrial Fibrillation Based on a Human Atrial Model

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Preliminary Simulation Study of Atrial Fibrillation Treatment Procedure Based on A Detailed Human Atrial Model

Simulation of Non-Transmural Ablation Lines That Effectively Block Electrical Signal Propagation in the Heart

Simple Model for Identifying Critical Regions in Atrial Fibrillation

Atrial fibrillation: Insights from animal models, computational modeling, and clinical studies

Simulation Research on Early Afterdepolarizations-mediated Ventricular Fibrillation Based on a Heart Model

Relevance of Ventricular Electrical Dispersion to Arrhythmogenesis in Ischemic Myocardium--a Simulation Study.

Virtual Electrophysiological Heart Model and Atrial Fibrillation : a Review

Patient-Specific Heart Model Towards Atrial Fibrillation

Influence of acute myocardial ischemia on arrhythmogenesis: a computational study

A Simple Model for Identifying Critical Structures in Atrial Fibrillation

Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation

Dispersion Of Refractoriness And Induction Of Reentry Due To Chaos Synchronization In A Model Of Cardiac Tissue

Algorithm Study on the Three-dimensional Cardiac Tissue Based on the Model of Ventricular Action Potential

A computational study on the influence of antegrade accessory pathway location on the 12-lead electrocardiogram in Wolff-Parkinson-White syndrome

Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation

Translational Research with Clinical Impact

Influence of Channel Blockers on Cardiac Alternans.